Development of an ARMS multiplex real-time PCR assay for the detection of HLA-B*13:01 genotype by detecting highly specific SNPs.
Pharmacogenet Genomics
; 34(2): 53-59, 2024 Feb 01.
Article
en En
| MEDLINE
| ID: mdl-38050734
ABSTRACT
OBJECTIVES:
HLA-B*1301 was strongly associated with Dapsone Hypersensitivity Syndrome (DHS). This study aimed to develop and validate a rapid and economical method for HLA-B*1301 genotyping.METHODS:
Two tubes multiplex real-time PCR detection system comprising amplification refractory mutation system primers and TaqMan probes was established for HLA-B*1301 genotyping. Sequence-based typing was applied to validate the accuracy of the assay.RESULTS:
The accuracy of the assay was 100% for HLA-B*1301 genotyping. The detection limit of the new method was 0.025 ng DNA. The positive rate of HLA-B*1301 in the Bouyei (20%, nâ =â 50) populations was significantly higher than that in the Uighur population (4%, nâ =â 100), Han (4.5%, nâ =â 200), and Tibetan (1%, nâ =â 100) ( P â <â 0.05).CONCLUSION:
The proposed method is rapid and reliable for HLA-B*1301 screening in a clinical setting.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Antígenos HLA-B
/
Polimorfismo de Nucleótido Simple
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article